Master Class: Process Development and Scale-Up in the Pharmaceutical Industry Module CH510 17 and 18 June 2014 School of Chemistry.

Slides:



Advertisements
Similar presentations
Due Diligence of Technology Mission Critical: The Rocky Research scientist, engineers & mfg specialist are dedicated to assist potential investors in.
Advertisements

W504 - Asbestos and other fibres Date Location. Welcome Opening comments Emergency Procedures Introductions.
The KLARA system on chemical handling Part of course on Basic Laboratory Safety, at Göteborgs University, 28 th of February 2013 Anders Thorén, Nordic.
Dr. Wayne Cooper and Mr. Dan Kimball
L5: GP TECHNIQUES / 1 Asian Productivity Organization, Tokyo Organization of the GP Techniques.
ATTENDANCE FORM 6th NORTH WEST LIPID FORUM 11 th June 2013, 09: YES, I am able to attend the meeting on Tuesday 11 th June 2013 To reserve your.
A workshop for STEM subjects on Sustainable Development The Higher Education Academy Session 3: STEM and ESD THE SUSTAINABLE PRACTITIONER.
Green Chemistry.
SUSTAINABLE PROCESS INDUSTRY EUROPEAN INDUSTRIAL COMPETTIVENESS TROUGH RESOURCE AND ENERGY EFFICIENCY SPIRE Brokerage event December 16 th 2013 Project.
SUSTAINABLE PROCESS INDUSTRY EUROPEAN INDUSTRIAL COMPETTIVENESS TROUGH RESOURCE AND ENERGY EFFICIENCY SPIRE Brokerage event December 16 th 2013 Project.
Pravin Amar Development Planners 14 July 2005, Assagay Hotel, 5pm Applicant: EnviroServ Waste Management (Pty) Ltd. Environmental Consultants Pravin Amar.
For more information, please contact: Special Programs Industrial Relations Dept. Tel.: +966 (013) Tel.: +966 (013) Fax :
PGCE CPD Materials Workshop Tuesday 16 th June 2009 David Hutton (Schools Liaison Officer)
Clinical Engineering The Royal Liverpool and Broadgreen University Hospitals NHS Trust NHS LIVERPOOL SHORT COURSES IN ELECTRICAL SAFETY ISO 9001: 2000.
ANAM ZAHRA 2462 BS.ES[2]. WATER POLLUTION SOURCES OF WATER POLLUTION.
Pharmaceutical Product Quality Assurance Through CMC Drug Development Process Presented by Darlene Rosario (Aradigm) 21 October 2003 Meeting of the Advisory.
Next START: September years part-time Mondays and Thursdays: 6:15 – 9:00.
COMPARABILITY PROTOCOLS ACPS March 12-13, 2003 Stephen K. Moore, Ph.D. Chemistry Team Leader CDER/Office of New Drug Chemistry Co-Chair, Comparability.
Professional Responsibilities of Engineers Mechanical Engineering Years 3 and 4 John Yates.
Guidance for Industry Process Validation: General Principles and Practices Dr. Mark Tucker, F. Hoffman-La Roche, Ltd.
Solid Catalysts – Synthesis and Characterisation Techniques Emmanuel Iro.
Custom Synthesis (R&D and cGMP)| Commercialization Expertise |Consulting Services.
Eli Lilly and Company is a world leader in the pharmaceutical industry. We create and deliver innovative pharmaceutical-based health care solutions that.
©2009 Association of Cost Engineers Ltd The information in this document is the property of The Association of Cost Engineers Ltd and may not be copied.
Number of unit : 3 Course type : Core Prerequisite: None.
Achieving and Demonstrating “Quality-by-Design” with Respect to Drug Release/dissolution Performance for Conventional or Immediate Release Solid Oral Dosage.
Mike Murray Chair of EFPIA EH&S AHG MPA Conference Uppsala
Visit to Strathclyde University Environmental Health Civil & Env. Engineering Department Wednesday, 5 th December 2012.
Nonclinical Studies Subcommittee Advisory Committee for Pharmaceutical Science CMC Issues for Screening INDs Eric B. Sheinin, Ph.D. Acting Deputy Director.
Integrated Foundation Year Co-ordinator:Mr Ian McCrum Room 5B18, Telephone extension (028)
Registration Fee : 15,900 Baht This fee does not include 7% VAT, accommodation, and transportation, but include 2 break and a lunch during the session.
FP7 Cooperation Work Programme NANOSCIENCES, NANOTECHNOLOGIES, MATERIALS AND NEW PRODUCTION TECHNOLOGIES - NMP.
Risk Based CMC Review Advisory Committee for Pharmaceutical Science October 22, 2003 Vilayat A. Sayeed, Ph.D. OGD, FDA.
American Chemical Society Careers In Chemistry. 1 2 American Chemical Society Provide State-of-the-Art Chemical Information Serving as a Premiere Professional.
Tempus CD-JEP Education and Culture Assiut University Coordinator Prof.Esmat Keheila Grant Holder.
Important informations
Impact of the changing undergraduate curriculum on research ethics Professor John Yates 2008 HEA National Teaching Fellow.
1 An Update on ICH Guideline Q8 – Pharmaceutical Development FDA Advisory Committee for Pharmaceutical Science: 5 Oct 2006 Dr John C Berridge Senior Regulatory.
Dial-a-Molecule A Grand Challenge for Chemistry and Chemical Engineering Prof. Richard Whitby University of Southampton.
Simulation Of Bioprocess ERT Modeling and Assessment in Process Development.
1 Children and chemical safety: framework for action to protect children from harmful exposures Presented on behalf of the IFCS Children & Chemical Safety.
The Annual ARIOPS Railway Occupational Health Conference 2008 “European Challenges, Opportunities and Threats to the UK Railway Industry” Monday 30th June.
Introduction to Hazard Communication An Employee Orientation & Training Course ?
Specific Safety Requirements on Safety Assessment and Safety Cases for Predisposal Management of Radioactive Waste – GSR Part 5.
RESEARCH METHODS IN TOURISM Nicos Rodosthenous PhD 07/02/ /2/20131Dr Nicos Rodosthenous.
General Aspects of Quality assessment of multisource interchangeable medicines Rutendo Kuwana Technical Officer, WHO, Geneva Training workshop: Assessment.
P1. Overview of Objectives & Agenda of Technical Meeting
Pembrokeshire Estates Engagement Project - PEEP Samantha Hancock Senior Environmental Health Officer Pembrokeshire County Council.
Green Chemistry as a tool to prevent
Regine Imperial 10 White. Universal Philosophy that aims to develop industrial procedures that have minimal environmental impact and use chemistry to.
Imete Welcome Day Jan Bartáček.
School of Mechanical, Materials and Manufacturing Engineering About this course Biomedical industries provide a rich diversity.
W w w. g a l c h i m i a. c o m The leading Medchem service provider in Spain.
Medicinal Chemistry Lecture – I Introduction and Course Overview Joseph O. Oweta B. Pharm (MUST)
PROCESS ANALYTICAL TECHNOLOGY – A REVIEW By Mr. Akash Mali DEPARTMENT OF PHARMACEUTICS, G.I.P.E.R., LIMB, SATARA. 1.
Prof. Chris Rayner and Dr. Xiaojun Lai
An Update on ICH Guideline – Pharmaceutical Development
8th Global Congress for Process Safety
Course Programme Day One
Lab Skills and Chemical Analysis
Master Class: Process Development and Scale-Up in the Pharmaceutical Industry Module CH and 27 April 2018 School of Chemistry.
Food Allergen Analysis and Management
(3rd July to 29th September)
Types of Chemistry Lists
WFAA Seminar AGENDA 17th October 2018– University of Chester
Proportion of total R&D expenditure by function in 2005
Research Data Management in the Time of the GDPR
Introduction to IT Audit
INTOSAI IT AUDIT TRAINING
Solid State Pharmaceutical Centre ( )
Presentation transcript:

Master Class: Process Development and Scale-Up in the Pharmaceutical Industry Module CH510 17 and 18 June 2014 School of Chemistry

Process Development and Scale-Up in the Pharmaceutical Industry As part of their structured PhD programme, NUI Galway’s School of Chemistry, in association with SSPC in UL, are providing a 2-day course on the development and scale-up of organic syntheses for the commercial manufacture of drug substances. The course will Focus on synthetic processes for “small molecule” drugs and address the organic, physical and analytical chemistry involved. Cover process selection and development, technology transfer and on-going optimisation with reference to the safety, environmental, engineering, quality and regulatory disciplines involved. Use real examples to illustrate the subject. The course will be delivered by Industrial practitioners Is aimed at: PhD students in chemistry and related disciplines. There will be a fee of €100 for non-NUIG attendees. Applications to dennis.smith@nuigalway.ie (087-6775481) Dillon Theatre, School of Chemistry 17 and 18 June 2014

Process Development and Scale-Up in the Pharmaceutical Industry On completion of the course, students will: Understand the considerations involved in designing a chemical process suitable for industrial manufacturing Appreciate the scientific disciplines involved in bringing a chemical process from laboratory to industrial scale Be familiar with the organic chemistry involved in the manufacture of some significant current drugs Be able to rationalise and discuss the mechanisms of organic reactions involved in the synthesis of drugs Appreciate the importance of the physical properties of APIs and understand approaches and techniques for their control ECTS Credits: 5 (on successful completion of assigned course work) Dillon Theatre, School of Chemistry 17 and 18 June 2014

Dillon Theatre, School of Chemistry 17 and 18 June 2014 Process Development and Scale-Up in the Pharmaceutical Industry Tuesday 17 June Session 1 Chair Prof Paul V. Murphy (Head of School of Chemistry, NUIG) 09.00 Registration 09.15 Welcome & Introduction Prof Paul V. Murphy (NUIG) 09.30 Process Research and Development. Part 1. Peter J. Harrington (University of Denver) Synthesis of Lipitor 10.30 Break Tea and coffee (Concourse) 11.00 Process Research and Development. Part 2. Peter J. Harrington 12.00 Technology Transfer to Manufacturing Facility John O’Callaghan (Roche) Scope and requirements of technology transfer 12.45 Lunch Soup and sandwiches (An Bhialann) Dillon Theatre, School of Chemistry 17 and 18 June 2014

Dillon Theatre, School of Chemistry 17 and 18 June 2014 Process Development and Scale-Up in the Pharmaceutical Industry Tuesday 17 June Session 2 Chair Dr Fawaz Aldabbagh (NUI Galway) 13.30 Quality Assurance Clare Desbonnet (Roche) Regulatory obligations Process validation 14.30 Analytical Controls Patricia Clancy (Roche) Specifications and test methods for drug substances In-process controls and process analytical technology (PAT) 15.30 Break Tea and coffee (Concourse) 16.00 Chemical Engineering Aspects Eoin Cleary (Roche) Selection and sizing of equipment Process flow and process “fits” 17.00 Process safety management Bill Fleming (Fleming Professional) Risk identification Quantified risk assessment 18.00 Close Dillon Theatre, School of Chemistry 17 and 18 June 2014

Dillon Theatre, School of Chemistry 17 and 18 June 2014 Process Development and Scale-Up in the Pharmaceutical Industry Wednesday 18 June Session 3 Chair Dr Niall Geraghty (NUI Galway) 9.00 Safety Testing Michael Kennedy (SPDS Ltd) Chemical reaction hazard assessment Dust and electrostatic hazard assessment Vent sizing 10.00 Environmental Management Seamus O’Grady (Roche) Licence requirements (ELVs) Waste minimisation 11.00 Break Tea and coffee (Concourse) 11.30 Process Optimisation at the Manufacturing Facility Dennis Smith (NUIG) Approaches to on-going development Case study - Mycophenolate Mofetil 12.30 Lunch Soup and sandwiches (An Bhialann) Dillon Theatre, School of Chemistry 17 and 18 June 2014

Dillon Theatre, School of Chemistry 17 and 18 June 2014 Process Development and Scale-Up in the Pharmaceutical Industry Wednesday 18 June Session 4 Prof Kieran Hodnett (UL/SSPC) 13.30 Solid State Properties of APIs Denise Croker (UL) Critical properties and test methods 14.15 Solid state properties and manufacturing John Collins (UL/SSPC) The impact of solid state properties on operations Operational technologies for control of solid state properties 15.15 Break Tea and coffee (Concourse) 15.30 Crystallisation and control of solid state properties Mark Barrett (APC/SSPC) 16.30 Case studies of process and product quality improvements arising from crystallisation optimisation John O’Reilly (Roche) 17.30 Close Dillon Theatre, School of Chemistry 17 and 18 June 2014